14-91870431-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006329.4(FBLN5):c.1186-46A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.479 in 1,605,466 control chromosomes in the GnomAD database, including 187,602 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 14925 hom., cov: 32)
Exomes 𝑓: 0.48 ( 172677 hom. )
Consequence
FBLN5
NM_006329.4 intron
NM_006329.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.48
Publications
14 publications found
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
- cutis laxa, autosomal dominant 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- cutis laxa, autosomal recessive, type 1AInheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- Charcot-Marie-Tooth disease, demyelinating, IIA 1HInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- demyelinating hereditary motor and sensory neuropathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- macular degeneration, age-related, 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary sensorimotor neuropathy with hyperelastic skinInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive cutis laxa type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 14-91870431-T-C is Benign according to our data. Variant chr14-91870431-T-C is described in ClinVar as Benign. ClinVar VariationId is 1227228.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.626 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FBLN5 | NM_006329.4 | c.1186-46A>G | intron_variant | Intron 10 of 10 | ENST00000342058.9 | NP_006320.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.427 AC: 64866AN: 152016Hom.: 14911 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
64866
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.493 AC: 122732AN: 248734 AF XY: 0.499 show subpopulations
GnomAD2 exomes
AF:
AC:
122732
AN:
248734
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.484 AC: 703977AN: 1453332Hom.: 172677 Cov.: 30 AF XY: 0.487 AC XY: 352041AN XY: 723338 show subpopulations
GnomAD4 exome
AF:
AC:
703977
AN:
1453332
Hom.:
Cov.:
30
AF XY:
AC XY:
352041
AN XY:
723338
show subpopulations
African (AFR)
AF:
AC:
8169
AN:
33268
American (AMR)
AF:
AC:
21794
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
AC:
13957
AN:
26096
East Asian (EAS)
AF:
AC:
25302
AN:
39658
South Asian (SAS)
AF:
AC:
46168
AN:
86018
European-Finnish (FIN)
AF:
AC:
26585
AN:
53382
Middle Eastern (MID)
AF:
AC:
2340
AN:
4208
European-Non Finnish (NFE)
AF:
AC:
530314
AN:
1106028
Other (OTH)
AF:
AC:
29348
AN:
59976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
19508
39016
58525
78033
97541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
15606
31212
46818
62424
78030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.427 AC: 64914AN: 152134Hom.: 14925 Cov.: 32 AF XY: 0.430 AC XY: 32026AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
64914
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
32026
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
10632
AN:
41514
American (AMR)
AF:
AC:
7112
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1858
AN:
3470
East Asian (EAS)
AF:
AC:
3323
AN:
5154
South Asian (SAS)
AF:
AC:
2584
AN:
4830
European-Finnish (FIN)
AF:
AC:
5362
AN:
10604
Middle Eastern (MID)
AF:
AC:
171
AN:
292
European-Non Finnish (NFE)
AF:
AC:
32537
AN:
67956
Other (OTH)
AF:
AC:
969
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1891
3782
5672
7563
9454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1849
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.